A RANDOMIZED CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL VERSUS CYCLOPHOSPHAMIDE FOR INDUCTION THERAPY IN ANCA ASSOCIATED SYSTEMIC VASCULITIS WITH RENAL INVOLVEMENT

被引：0
|
作者：
Chen, Nan
Li, Xin [1 ]
Zhang, Wen [1 ]
Shen, Pingyan [1 ]
Yu, Haijing [1 ]
Chen, Yongxi [1 ]
Ren, Hong [1 ]
Ni, Liyan [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：61 / 62
页数：2
相关论文
共 50 条
  • [21] Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
    Jones, Rachel
    Tervaert, Jan Willem Cohen
    Hauser, Thomas
    Luqmani, Raashid
    Peh, Chen A. U.
    Savage, Caroline
    Segelmark, Marten
    Tesar, Vladimir
    Van Paassen, Pieter
    Walsh, Michael
    Walsh, Dorothy
    Westman, Kerstin
    Jayne, David
    APMIS, 2009, 117 : 78 - 78
  • [22] Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide
    Christian Burchardi
    Detlef Schlöndorff
    Nature Clinical Practice Nephrology, 2006, 2 : 314 - 315
  • [23] MYCOPHENOLATE MOFETIL VERSUS CYCLOPHOSPHAMIDE FOR THE INDUCTION OF REMISSION IN NON-LIFE-THREATENING RELAPSES OF PR3 AND MPO-ANCA ASSOCIATED VASCULITIS
    Tuin, Janneke
    Stassen, Patricia M.
    Bogdan, Daria I.
    Tervaert, Jan-Willem Cohen
    Sanders, Jan-Stephan F.
    Stegeman, Coen A.
    RHEUMATOLOGY, 2017, 56 : 16 - 16
  • [24] Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus NephritisA Meta-Analysis of Randomized Controlled Trials
    Lin-lin Liu
    Yi Jiang
    Li-ning Wang
    Li Yao
    Zi-long Li
    Drugs, 2012, 72 : 1521 - 1533
  • [25] Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis A Meta-Analysis of Randomized Controlled Trials
    Liu, Lin-lin
    Jiang, Yi
    Wang, Li-ning
    Yao, Li
    Li, Zi-long
    DRUGS, 2012, 72 (11) : 1521 - 1533
  • [26] Mycophenolate mofetil (CellCept, MMF) therapy of systemic lupus erythematosus (SLE) and ANCA vasculitis (V).
    Hebert, LA
    Cosio, FG
    Bay, WH
    Hernandez, R
    Lautman, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0415 - A0415
  • [27] CYCLOPHOSPHAMIDE INDUCTION TREATMENT IN ANCA-ASSOCIATED VASCULITIS WITH RENAL AND PULMONARY INVOLVEMENT: OUTCOMES AND SIDE EFFECTS
    Vezzani, Valeria
    Di Vito, Roberto
    Orfeo, Chiara Alessia
    Capone, Martina
    Iarlori, Luigia
    Marra, Pietro
    Nolletti, Lorenzo
    Bonomini, Andmario
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I351 - I351
  • [28] Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement A comparative cohort study
    Speer, Claudius
    Altenmueller-Walther, Christine
    Splitthoff, Jan
    Nusshag, Christian
    Kaeble, Florian
    Reichel, Paula
    Morath, Christian
    Zeier, Martin
    Bergner, Raoul
    Schaier, Matthias
    MEDICINE, 2021, 100 (29) : E26733
  • [29] The Role of Mycophenolate Mofetil for the Induction of Remission in ANCA-Associated Vasculitis: A Meta-Analysis
    Xiong, Anji
    Xiong, Chen
    Yang, Guancui
    Shuai, Yu
    Liu, Deng
    He, Linqian
    Guo, Zepeng
    Zhang, Liangwen
    Liu, Yi
    Yang, Yuan
    Cui, Beibei
    Shuai, Shiquan
    FRONTIERS IN MEDICINE, 2021, 8
  • [30] Tacrolimus versus mycophenolate mofetil for induction treatment of severe lupus nephritis: A randomized controlled trial
    Mok, C. C.
    Tong, K. H.
    Siu, Y. P.
    Yin, C. W.
    Ng, W. L.
    To, C. H.
    Wong, S. H.
    Ho, Y. W.
    Au, T. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 473 - 473
12345